response to microenvironmental signals, miRNAs regulate macrophage polarization by modulating transcription factors, that induce expression of M1 (miR-21, miR-27a/b, miR-130a/b, and miR-155) and M2 (miR-125a/b, miR-146a/b, miR-124, miR-181a, and let-7c). [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Epithelial-mesenchymal transition (EMT) is an important catcher for connecting microenvironment and tumor cells. Current evidence suggests that EMT can be divided into 3 subtypes. Type 1 EMT involves in evolutional development. Type 2 EMT relates to epithelial or endothelial cells transitioning to resident tissue fibroblasts, which is induced in response to persistent inflammation; type 3 EMT is seen in carcinogenesis or metastasis. 17 It is recognized that the 3 subtypes of EMT have some phenotypic similarities. For example, increased expression of N-cadherin or vimentin, and complete or partial loss of epithelial markers such as E-cadherin and ZO-1. [17] [18] [19] In general, EMT is accompanied by a loss of membrane localization of E-cadherin: a "cadherin transition" from E-cadherin to N-cadherin. Level changes of epithelial and mesenchymal markers are often used to distinguish between EMT and partial EMT phenotypes. 20, 21 Therefore, as a hallmark of EMT, cadherin switching stands a unique biological position.
In our previous study, 22 we found that miR-362-3p levels in gastric cancer (GC) cell lines are higher than in normal gastric mucosa cell lines. Poorly differentiated GC cell lines (AGS and MKN45) with high expression of miR-362-3p showed lower expression of CD82 at both mRNA and protein levels, whereas highly differentiated GC cell lines (MKN28 and MGC803) showed only low expression levels of miR-362-3p. Furthermore, we also identified that miR-362-3p directly regulated CD82, one of the most important members of the tetraspanin family, which negatively regulated EMT progression in several human cancers. But is this a phenomenon confined to GC, or does it exist among other digestive cancers as well? To answer this question, we investigated the effect of miR-362-3p on hepatocellular carcinoma (HCC) cells after transformation of cells into M1 and M2 macrophages in the tumor microenvironment, and tried to explore whether miR-362-3p can be used as a core factor to connect TAMs and HCC cells, which then enlarge the EMT process. 
| MATERIAL S AND ME THODS

| Cell line culture
| Coculture experiments
As described above, THP-1 cells were induced into M1 or M2 macrophages. THP-1 cells were seeded in Transwell inserts (0.4 -μm pores; Corning Costar, Corning, NY, USA). The inserts were placed in a 12-well plate with preseeded HCC cells. The inserts containing newly generated THP-1 macrophages were replaced each day.
Cocultures were maintained for 3 days before collection of HCC cells.
| Chromatin immunoprecipitation-PCR
Chromatin immunoprecipitation-PCR was carried out using Smad2/3
Ab (ab202445; Abcam, Cambridge, MA, USA). Briefly, DNA and proteins were cross-linked using formaldehyde and subsequently sonicated. The DNA was then immunoprecipitated with agarose A/G beads and Ab followed by proteinase K digestion. Finally, the precipitated DNA was subjected to PCR amplification in agarose gel.
The primer sequences covering the predicted Smad binding sites in the promoter of miR-362-3p are described in Table 1 .
| Electrophoretic mobility-shift assay
Electrophoretic mobility-shift assay was undertaken with biotinlabeled probes and nuclear extracts obtained from HEK293 cells.
DNA-protein complexes were separated in a 6% polyacrylamide gel and electrophoretically transferred to nylon membranes. The biotin-labeled DNA was detected by chemiluminescence using promoter were synthesized as follows: SBE1 forward (F), 5′-tgagagaacagacaaaatgtgt-3′, SBE1 reverse (R), 5′-acacattttgtctgttctctca-3′; SBE2-F, 5′-gagagtgctgtctgaatgcaat-3′, SBE2-R, 5′-attgcattcagacagcactctc-3′; SBE3-F, 5′-agccttcttgtctgctccccctct-3′, SBE3-R, 5′-agagggggagcagacaagaaggct-3′.
| RNA isolation and quantitative real-time PCR
Real-time PCR was carried out as described in our previous report. 22 
| Western blot analysis
Western blot analysis was undertaken as described in our previous reports. 22, 23 Primary Abs were purchased from Abcam: for GAPDH (ab8235, diluted 1:3000) and CD82 (ab66400), Smad2/3 (ab63399), Smad4 (ab40759), E-cadherin (ab76055), and N-cadherin (ab98952; all diluted 1:1000). GAPDH was used as an internal control.
| Vector and lentivirus production and cell transfection
Lentiviral vectors production was carried out as described in our previous report. 22 In brief, the shRNAs targeting miR-362-3p were inserted into the pGreenPuro shRNA expression lentivector. The shRNAs were designed to be asymmetric and were expressed by the H1 promoter (GenePharma, Shanghai, China). This structure was used to knockdown miR-362-3p and named as miR-362-3p shRNA.
The shRNAs were transfected into MHCC-97H cells. Stable cell lines were obtained by using 5 μg/mL puromycin (Sigma-Aldrich) selection for approximately 2 weeks.
| Cell invasion assays
Cell invasion assays were carried out as described previously. 23, 24 Briefly, THP-1 cells were first induced into M2 macrophages as de- 
| Wound healing assay
A cell migration assay was undertaken using the wound healing method as described in our previous report. 25 Briefly, HCC cells 
| Immunofluorescence staining
Immunofluorescence staining assays were carried out as described previously. 23 Cells were incubated overnight with the primary Abs 
TA B L E 1 Primers for real-time RT-PCR and ChIP-PCR
Nuclei of cells were stained with DAPI (Sigma-Aldrich). Images were obtained using a Zeiss LSM 510 META Confocal microscope using 20×/0.5 w and 40×/1.2 w objectives.
| Assessment of tumorigenicity in vivo
Tumorigenicity in vivo was analyzed as described in our previous report. 22, 26 In brief, miR-362-3p shRNA or Control shRNA-infected , and epithelial-mesenchymal transition markers (E-cadherin and N-cadherin) was examined in HCC cells and normal human hepatocytes. *P < .05 vs normal human hepatocytes, **P < .01 vs normal human hepatocytes. C, Spearman's correlations between the expression of miR-362-3p and its downstream proteins (CD82, E-cadherin, and N-cadherin) in HCC cells by cervical dislocation. Livers were resected and photographed using a high-definition digital camera.
| Statistical analysis
All statistical analyses were undertaken using SPSS 17.0 software (IBM, Armonk, NY, USA). Data are presented as mean ± SD. The statistical significance of multiple group comparisons was calculated using 1-or 2-way ANOVA depending on the experiment, while the statistical significance of 2-group unpaired comparisons was calculated using
Student's t test. Correlation analysis was carried out to assess the relationship between miR-362-3p level and CD82, E-cadherin, or N-cadherin expression. The analysis of quantitative PCR results for miRNAs was calculated using the 2 −ΔΔCt method. 27 Differences between groups were considered statistically significant at P < .05 and highly statistically significant at P < .01.
| RE SULTS
| MicroRNA-362-3p is upregulated and mediates its target CD82 or EMT markers in HCC cells
First, we confirmed that miR-362-3p expression was increased in HCC cells using stem-loop quantitative real-time PCR ( Figure 1A ,B), which was consistent with a previous study by Shen et al. 28 In addition, we explored the relationship between the expression of miR-362-3p and its target gene CD82 as well as EMT markers (E-cadherin and N-cadherin) in different HCC cell lines. CD82 was highly expressed in HCC cells with low expression of miR-362, and levels of epithelial marker E-cadherin were also elevated, whereas expression of mesenchymal marker N-cadherin was decreased ( Figure 1A,B) .
The miR-362-3p level was negatively correlated with expression of CD82 (R = −0.792, P = .0337), and was positively related to N-cadherin (R = 0.849, P = .0158; Figure 1C ). These data indicated that miR-362-3p was highly expressed in HCC and it could possibly modulate its target CD82 and EMT markers. Although the relationship between miR-362-3p and E-cadherin did not achieve statistical significance (P = .0514) due to the low repeats of experiments, the trend towards a positive correlation was very clear (R = −0.751; Figure 1C ).
| MicroRNA-362-3p expression significantly promotes proliferation, invasion, and metastasis of HCC cells
To evaluate the roles of miR-362-3p in cell migration and invasion, wound healing and Transwell invasion assays were carried out using HCC cells. Wound healing assays showed that miR-362-3p mimics markedly increased HCC cell migration, whereas miR-362-3p
inhibitors significantly inhibited HCC cell migration (Figure 2A,B) .
Results of Transwell invasion assays indicated that the invasiveness of HCC cells transfected with miR-362-3p mimics was significantly increased, whereas it was decreased in those transfected with the F I G U R E 2 MicroRNA (miR)-362-3p expression significantly promotes proliferation, invasion, and metastasis of hepatocellular carcinoma cells. A,B, Cell migration activity was measured by wound healing assay after transfection with miR-362-3p mimics and miR-362-3p inhibitors. *P < .05; **P < .01. C-F, To evaluate cell invasiveness, Transwell assays were carried out on miR-362-3p mimics and miR-362-3p inhibitors. *P < .05; **P < .01 miR-362-3p inhibitors ( Figure 2C-F) . These results indicate that miR-362-3p regulates the malignant biological behavior of HCC cells. 
| Transforming growth factor-β stimulates miR-362-3p and its downstream proteins in HCC cells
We then investigated whether TGF-β regulated miR-362-3p expression in HCC cells. The levels of miR-362-3p in HCC cells were analyzed after treatment with increasing concentrations of TGF-β over different durations. As shown in Figure 4A Figure 4A ). We then tested the optimal stimulatory concentration of TGF-β on miR-362-3p. Results showed that TGF-β at 5 ng/mL or higher induced miR-362-3p expression in HCC cells ( Figure 4B ).
In addition, the effects of TGF-β on expression of its downstream signaling proteins and EMT markers were detected. As expected, TGF-β stimulated the expression of Smad2/3 and N-cadherin while it downregulated E-cadherin expression. However, Smad4 expression remained unchanged. Furthermore, TGF-β also reduced CD82 expression, the target of miR-362-3p ( Figure 4C ).
| M2 macrophages promote miR-362-3p expression and its effector protein change via TGF-β signaling
It is well known that the differentiation of macrophages into the M2 subtype is reflected by increased expression of TGF-β. Therefore, we tested the effect of TGF-β on the expression of miR-362-3p and HCC cells during the directed polarization of macrophages. Macrophages . THP1 cells were incubated with 20 ng/mL γ-interferon (IFN-γ) and 100 ng/mL lipopolysaccharide (LPS) for 24 h after treatment with PMA (25 ng/mL) for 36 h. Culture-derived M1 macrophages were positive for CD86 but not for CD163 (lower panel). B, Active TGF-β is released by 2 types of differentiated macrophages. C, Expression of miR-362-3p was detected in hepatocellular carcinoma (HCC) cells cocultured with 2 types of differentiated macrophages. D, Subsequent effector protein expression was analyzed by western blot in HCC cells cocultured with 2 types of differentiated macrophages. E, Epithelial-mesenchymal transition markers (E-cadherin and N-cadherin) expression in HCC cells in experimental groups were detected by immunofluorescence using confocal microscopy. Bars represent mean ± SD. *P < .05; **P < .01
Subsequently, E-cadherin expression was downregulated and N-cadherin expression was upregulated in GC and HCC cells ( Figure 5D ).
However, unlike the exogenous TGF-β stimulation experiments, M2
macrophages not only increased Smad2/3 phosphorylation, but also significantly enhanced Smad4 expression. Immunofluorescence showed that morphology of HCC cells cocultured with M2 macrophages was changed. The gap between cells is larger compared with control or cells cocultured with M1 macrophages, accompanied by a decrease in the expression of E-cadherin, and an increase of N-cadherin ( Figure 5E ). This phenomenon might occur because M2 macrophages also secrete other cytokines in addition to TGF-β.
| Transforming growth factor-β signals regulate the EMT process in tumor cells by modulating miR-362-3p and its related protein expression
To further confirm our findings, we took advantage of a TGFβRI inhibitor (SB431542) and a specific inhibitor of Smad3 (SIS3). 29 As shown in Figure 6A In addition, invasion assays results suggested that both endogenous and exogenous TGF-β signals enhanced the invasive activity of HCC cells ( Figure 6E,F) . Combined with the data above, we believe that TGF-β regulates the EMT process by modulating miR-362-3p
and its effector protein expression.
| Smad2/3 positively regulates transcription of miR-362-3p
To explore the relationship between the TGF-β/Smads signaling pathway and miR-362-3p, we analyzed the promoter F I G U R E 6 Endogenous and exogenous transforming growth factor (TGF)-β signals regulate the epithelial-mesenchymal transition process in tumor cells by regulating microRNA (miR)-362-3p and its effector protein expression. A-D, Hepatocellular carcinoma (HCC) cells in the coculture system were treated with TGFβRI inhibitor (SB431542) and specific inhibitor of Smad3 (SIS3), followed by detection of proteins and miR-362-3p expression using western blotting and real-time PCR, respectively. E,F, Transwell invasion assays were used in HCC cells treated with endogenous or exogenous TGF-β in the presence or absence of inhibitors. Cells were stained and counted using light microscopy (magnification, ×200). Bars represent mean ± SD. *P < .05; **P < .01
region of miR-362-3p and screened homologous sequences of SBEs (CAGACA) using bioinformatics analysis. Through sequence analysis, we found that multiple SBE sequences were repeatedly distributed in the promoter region of miR-362-3p
( Figure 7A ).
Chromatin immunoprecipitation analysis was then carried
out in HEK293 cells to determine whether Smad2/3 binds the miR-362-3p promoter in cell culture. Chromatin was immunoprecipitated using a Smad2/3 Ab, and PCR amplification was carried out using the DNA fragment of the expected size as a template. The
ChIP-PCR experiments showed that the SBE3 group did not have a specific band (191 bp) consistent with the input DNA, indicating that Smad2/3 did not bind to SBE3 in the transcription region.
However, specific bands were amplified in both the SBE1 (277 bp) and SBE2 (374 bp) groups, consistent with their corresponding input DNA, suggesting that Smad2/3 might regulate the expression of mir-362-3p by binding SBE1 and SBE2 in the near-transcriptional region ( Figure 7B ). promoter by Smad2/3 was direct or indirect, we undertook an EMSA using oligonucleotide probes derived from the miR-362-3p promoter region. We designed 3 oligonucleotides named SBE1, SBE2, and SBE3.
Nuclear extracts were prepared from HEK293 cells. As shown in Figure 7C (lanes 3, 7, and 11), the retarded bands were detected with 
| D ISCUSS I ON
Chronic inflammatory stimuli play a role in the progression of various tumors, including HCC. [30] [31] [32] The recruitment and differentiation of macrophages occurs during inflammation, in which immune imbalance can occur during tumorigenesis due to the simultaneous processing of both anti-and pro-tumorigenic signals. In this process, macrophage heterogeneity is depending on inflammatory molecules in the microenvironment. [33] [34] [35] In return, differently differentiated macrophages also affect the tumor microenvironment by releasing cytokines. [36] [37] [38] The term "TAM" usually refers to macrophages that infiltrate tumors. Among them, M2 macrophages participate in immunoregulation by promoting the Th2-type immune response and supporting further tumor progression through the release of vascular endothelial growth factor and TGF-β. 39, 40 Recently, miRNA-transcription factor networks have been found to be involved in macrophage polarization, which participates in the Some reports have indicated that macrophage infiltration and release of inflammatory factors mediate the regulation of miRNAs during tumorigenesis. 7, 41 Our study showed that M2 macrophages regulated Smad2/3 binding to the miR-362-3p promoter by releasing TGF-β, leading to overexpression of miR-362-3p.
In conclusion, our study showed that miR-362-3p overexpression in HCC cells was associated with M2 differentiation of macrophages partly through autocrine regulation of TGF-β expression.
Based on these data, we speculate that miR-362-3p might serve as a core factor to connect the TGF-β/Smads pathway in TAMs and the tetraspanin network in HCC and GC cells, facilitating the EMT process ( Figure 8 ). This finding provides a rationale for antagonizing macrophage-directed polarization to inhibit HCC. 
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